BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36174397)

  • 1. Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.
    Yan J; Kothur K; Innes EA; Han VX; Jones HF; Patel S; Tsang E; Webster R; Gupta S; Troedson C; Menezes MP; Antony J; Ardern-Holmes S; Tantsis E; Mohammad S; Wienholt L; Pires AS; Heng B; Guillemin GJ; Guller A; Gill D; Bandodkar S; Dale RC
    EBioMedicine; 2022 Oct; 84():104280. PubMed ID: 36174397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation.
    Yan J; Kothur K; Mohammad S; Chung J; Patel S; Jones HF; Keating BA; Han VX; Webster R; Ardern-Holmes S; Antony J; Menezes MP; Tantsis E; Gill D; Gupta S; Kandula T; Sampaio H; Farrar MA; Troedson C; Andrews PI; Pillai SC; Heng B; Guillemin GJ; Guller A; Bandodkar S; Dale RC
    EBioMedicine; 2023 May; 91():104589. PubMed ID: 37119734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a translational inflammation panel for the quantification of cerebrospinal fluid Pterin, Tryptophan-Kynurenine and Nitric oxide pathway metabolites.
    Yan J; Han VX; Heng B; Guillemin GJ; Bandodkar S; Dale RC
    EBioMedicine; 2022 Mar; 77():103917. PubMed ID: 35279631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms.
    Yamamoto H; Shindo I; Egawa B; Horiguchi K
    Pediatr Neurol; 1994 Feb; 10(1):9-12. PubMed ID: 8198681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
    Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
    Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid metabolites in tryptophan-kynurenine and nitric oxide pathways: biomarkers for acute neuroinflammation.
    Yan J; Kuzhiumparambil U; Bandodkar A; Bandodkar S; Dale RC; Fu S
    Dev Med Child Neurol; 2021 May; 63(5):552-559. PubMed ID: 33336374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms.
    Mu C; Choudhary A; Mayengbam S; Barrett KT; Rho JM; Shearer J; Scantlebury MH
    EBioMedicine; 2022 Feb; 76():103833. PubMed ID: 35090836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis.
    Tömösi F; Kecskeméti G; Cseh EK; Szabó E; Rajda C; Kormány R; Szabó Z; Vécsei L; Janáky T
    J Pharm Biomed Anal; 2020 Jun; 185():113246. PubMed ID: 32182446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
    Heyes MP; Saito K; Devinsky O; Nadi NS
    Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures.
    Muñóz-Hoyos A; Molina-Carballo A; Rodríguez-Cabezas T; Uberos-Fernández J; Ruiz-Cosano C; Acuña-Castroviejo D
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):667-77. PubMed ID: 9497873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of LC-MS/MS methods for quantitative analysis of kynurenine pathway metabolites in human plasma and cerebrospinal fluid.
    Khetarpal V; Herbst T; Akhtar S; LaFayette A; Miller D; Farnham J; Steege T; Miao Z; Marks B; Ledvina A; Dominguez C
    Bioanalysis; 2023 Jun; 15(11):637-651. PubMed ID: 37170582
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy.
    Żarnowska I; Wróbel-Dudzińska D; Tulidowicz-Bielak M; Kocki T; Mitosek-Szewczyk K; Gasior M; Turski WA
    Seizure; 2019 Jul; 69():265-272. PubMed ID: 31129366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of kynurenine metabolites and explorative metabolomics using liquid chromatography-mass spectrometry: A novel accurate method applied to serum and plasma samples from a large healthy cohort.
    Eggertsen PP; Hansen J; Andersen ML; Nielsen JF; Olsen RKJ; Palmfeldt J
    J Pharm Biomed Anal; 2023 Apr; 227():115304. PubMed ID: 36827735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
    Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
    Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Effects of Hypothermia and SZR72 on Cerebral Kynurenine and Kynurenic Acid in a Piglet Model of Hypoxic-Ischemic Encephalopathy.
    Domoki F; Tóth-Szűki V; Kovács V; Remzső G; Körmöczi T; Vécsei L; Berkecz R
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.